-
EP3863666
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3863666
| EP3863666 - TREATMENT AND PREVENTION OF MALARIA BASED ON THE ANTIGEN PFRH5 AND ANTIBODIES AGAINST THE SAME [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 09.05.2024 Database last updated on 19.07.2024 | |
| Former | Request for examination was made Status updated on 16.07.2021 | ||
| Former | The international publication has been made Status updated on 18.04.2020 | ||
| Former | unknown Status updated on 01.11.2019 | Most recent event Tooltip | 10.05.2024 | First examination report | Applicant(s) | For all designated states Oxford University Innovation Limited Buxton Court 3 West Way Oxford, Oxfordshire OX2 0JB / GB | [2021/33] | Inventor(s) | 01 /
DRAPER, Simon c/o Jenner Institute Laboratories Old Road Campus Research Building Roosevelt Drive Oxford Oxfordshire OX3 7DQ / GB | 02 /
HIGGINS, Matthew c/o Department of Biochemistry University of Oxford South Parks Road Oxford Oxfordshire OX1 3QU / GB | 03 /
ALANINE, Daniel G. W. c/o Jenner Institute Laboratories Old Road Campus Research Building Roosevelt Drive Oxford Oxfordshire OX3 7DQ / GB | [2021/33] | Representative(s) | Gregson, Anna Louise, et al Mathys & Squire The Shard 32 London Bridge Street London SE1 9SG / GB | [2021/33] | Application number, filing date | 19790732.2 | 10.10.2019 | [2021/33] | WO2019GB52885 | Priority number, date | GB20180016542 | 10.10.2018 Original published format: GB 201816542 | GB20190007609 | 29.05.2019 Original published format: GB 201907609 | [2021/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO2020074908 | Date: | 16.04.2020 | Language: | EN | [2020/16] | Type: | A2 Application without search report | No.: | EP3863666 | Date: | 18.08.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 16.04.2020 takes the place of the publication of the European patent application. | [2021/33] | Search report(s) | International search report - published on: | EP | 22.05.2020 | Classification | IPC: | A61K39/015, C07K16/20 | [2021/33] | CPC: |
C07K16/205 (EP,US);
A61K39/015 (EP,US);
A61K39/39575 (US);
A61P33/06 (US);
C12N15/115 (US);
A61K2039/5256 (US);
A61K2039/5258 (US);
A61K2039/53 (US);
A61K39/00 (EP,US);
C07K2317/31 (US);
C07K2317/56 (US);
C07K2317/565 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/33] | Title | German: | BEHANDLUNG UND VORBEUGUNG VON MALARIA AUF DER BASIS DES ANTIGENS PFRH5 UND ANTIKÖRPER DAGEGEN | [2021/33] | English: | TREATMENT AND PREVENTION OF MALARIA BASED ON THE ANTIGEN PFRH5 AND ANTIBODIES AGAINST THE SAME | [2021/33] | French: | TRAITEMENT ET PRÉVENTION DU PALUDISME | [2021/33] | Entry into regional phase | 07.05.2021 | National basic fee paid | 07.05.2021 | Designation fee(s) paid | 07.05.2021 | Examination fee paid | Examination procedure | 07.05.2021 | Amendment by applicant (claims and/or description) | 07.05.2021 | Examination requested [2021/33] | 07.05.2021 | Date on which the examining division has become responsible | 08.05.2024 | Despatch of a communication from the examining division (Time limit: M04) | Fees paid | Renewal fee | 20.10.2021 | Renewal fee patent year 03 | 14.10.2022 | Renewal fee patent year 04 | 16.10.2023 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2012046081 (GENOME RES LTD [GB], et al) [A] 1-10,12,14,15,18-24 * page 3, paragraphs 3-9; figures 7,8 * * page 9, paragraphs 2-5 *; | [AD]WO2012114125 (ISIS INNOVATION [GB], et al) [AD] 5-10,12,14,15,18-23 * page 27, paragraphs 2-5; examples 2,3; claims 1,4,12 *; | [AD]WO2016016651 (ISIS INNOVATION [GB]) [AD] 1-10,12,14,15,18-24 * page 3, line 5 - page 6, line 10 * * page 19, line 1 - page 21, line 6; claim 1 *; | [XPI] - ALANINE DANIEL G W ET AL, "Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies", CELL, (20190627), vol. 178, no. 1, doi:10.1016/J.CELL.2019.05.025, ISSN 0092-8674, page 216, XP085721262 [XP] 1,4-8,10,12,14,15,18-24 * abstract * * page 217, paragraph Results - page 225; figures 3,5,7 * * page 225, paragraph Discussion - page 226 * [I] 2,3,9 DOI: http://dx.doi.org/10.1016/j.cell.2019.05.025 | [A] - WILLIAMS A R ET AL, "Enhancing blockade of Plasmodium falciparum erythrocyte invasion: assessing combinations of antibodies against PfRH5 and other merozoite antigens", PLOS PATHOGENS, PUBLIC LIBRARY OF SCIENCE, US, vol. 8, no. 11, doi:10.1371/JOURNAL.PPAT.1002991, ISSN 1553-7374, (20120101), pages e1002991 - 1, (20121108), XP002727582 [A] 1-10,12,14,15,18-24 * abstract * * page 3, column r, paragraph 3 - page 5, column l, paragraph 3 * DOI: http://dx.doi.org/10.1371/journal.ppat.1002991 | [A] - VOLZ JENNIFER C ET AL, "Essential Role of the PfRh5/PfRipr/CyRPA Complex during Plasmodium falciparum Invasion of Erythrocytes", CELL HOST & MICROBE, ELSEVIER, NL, (20160630), vol. 20, no. 1, doi:10.1016/J.CHOM.2016.06.004, ISSN 1931-3128, pages 60 - 71, XP029639430 [A] 1-10,12,14,15,18-24 * the whole document * DOI: http://dx.doi.org/10.1016/j.chom.2016.06.004 | by applicant | WO2012114125 | WO2012172277 | WO2016016651 | WO2018055331 | - A. L. GOODMANS. J. DRAPER, Ann. Trop. Med. Parasitol., (20100000), vol. 104, page 189 | - KABAT et al., Ann. NY Acad, Sci., (19710000), vol. 190, pages 382 - 391 | - D. H. J. BUNKAP. G. STOCKLEY, Nature Reviews Microbiology, (20060000), vol. 4, page 588 | - GEALL, A.J. et al., Proc Natl Acad Sci USA, (20120000), vol. 109, no. 36, pages 14604 - 9 | - HAJITOU et al., Cell, (20060000), vol. 125, no. 2, pages 385 - 398 | - BRUNE et al., Sci. Rep., (20160000), vol. 19, no. 6, page 19234 | - FORBES, E.K. et al., J Immunol, (20110000), vol. 187, no. 7, pages 3738 - 50 | - SHEEHY, S.H. et al., Mol Ther, (20120000), vol. 20, no. 12, pages 2355 - 68 | - PORTER, D.W. et al., Vaccine, (20110000), vol. 29, no. 43, pages 7514 - 22 | - BRUDER, J.T. et al., Vaccine, (20100000), vol. 28, no. 18, pages 3201 - 10 | - TINE, J.A. et al., Infect Immun, (19960000), vol. 64, no. 9, pages 3833 - 44 | - IBRAHIMI, A. et al., Hum Gene Ther, (20090000), vol. 20, no. 8, pages 845 - 60 | - HENIKOFFHENIKOFF, Proc. Natl. Acad. Sci. USA, (19920000), vol. 89, pages 10915 - 10919 | - PICHYANGKUL, S. et al., Vaccine, (20090000), vol. 28, no. 2, pages 452 - 62 | - SPENCER, A.J. et al., PLoS One, (20120000), vol. 7, no. 10, page e33555 | - BACHMANN, M.F. et al., Nat Rev Immunol, (20100000), vol. 10, no. 11, pages 787 - 96 | - WU, Y. et al., Proc Natl Acad Sci USA, (20060000), vol. 103, no. 48, pages 18243 - 8 | - BISWAS, S. et al., PLoS One, (20110000), vol. 6, no. 6, page e20977 | - SPRING, M.D. et al., PLoS ONE, (20090000), vol. 4, no. 4, page e5254 | - BUSHELL et al., Genome research, (20080000), vol. 18, no. 4, pages 622 - 630 | - DOUGLAS et al., Nature communications, (20140000), vol. 2, page 601 | - WRIGHT et al., Nature, (20140000), vol. 515, no. 7527, page 427 | - DOUGLAS et al., Nature communications, (20150000), vol. 2, page 601 |